PARP1 and ovarian carcinoma: In addition to affecting proliferation, migration, apoptosis and autophagy, MEnZn‐CuO NPs can also produce a combined autophagy and lethal effect with PARP inhibitors by inducing HR gene downregulation to inhibited ovarian cancer.